Generic Name and Formulations:
Phenylephrine 1%, ketorolac 0.3%; intraocular soln after dilution.
Indications for OMIDRIA:
To maintain pupil size by preventing intraoperative miosis and reducing post-op ocular pain during cataract surgery or intraocular lens replacement, when added to an ocular irrigating solution.
Adults and Children:
Dilute 4mL of solution in 500mL of ocular irrigating solution. Use as needed for surgical procedure.
May elevate blood pressure. Aspirin or NSAID sensitivity. History of asthma. Pregnancy (avoid in 3rd trimester). Nursing mothers.
Alpha-1 agonist + NSAID.
Eye irritation, posterior capsule opacification, increased intraocular pressure, anterior chamber inflammation.
Single-patient-use vials (4mL)—4, 10
Clinical Pain Advisor Articles
- Opioids: Clinician Concern and Prescribing Practices
- Quantity of Opioids Prescribed Linked to Higher Patient-Reported Consumption
- Ensuring Safety During Long-Term Opioid Therapy
- Screening for Hyperglycemia Prior to Steroid Injections for Chronic Pain
- Drug Overdose Mortality Rates Rising in the United States
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Intervention by Pharmacists May Effectively Reduce Use of Inappropriate Medications in the Elderly
- Tips Provided for Budgeting in Medical Residency
- Give Thanks: The Role of Gratitude in Combating Burnout
- Persistent Back Pain Linked to Earlier Mortality in Older Women
- Cannabinoids May Be Effective on Experimental Pain Threshold and Tolerance, Not Intensity
- PainDETECT May Not Be Optimal to Detect Neuropathic Components of Orofacial Pain